Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
FYdprBKANHn8qstD